Instrument Inactif
Secteur Noven Pharmaceuticals, Inc.
Actions
US6700091092
Recherche biotechnologique et médicale
|
Cours en clôture
Autres places de cotation
|
||
| - USD | - |
|
| 30/11/-1 | Noven Pharmaceut. : approbation d'Exforge par l'autorité sanitaire américaine | AG |
| 30/11/-1 | Noven Pharmaceut. : Autorisation de l'UE pour le Glivec (Novartis) contre la leucémie | AG |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0,00% | - | - | - | - | - | - | - | 0 | |
| +1,68% | +3,55% | +19,07% | +14,55% | +8,33% | +4,86% | +10,97% | -12,97% | +260,52% | 49,42 Md | |
| +0,72% | +1,93% | +28,72% | +97,55% | +139,96% | +424,51% | +624,25% | +502,17% | - | 40,34 Md | |
| +2,54% | +2,84% | +13,76% | +21,11% | -7,29% | +27,06% | -3,62% | -16,01% | +192,63% | 34,01 Md | |
| +0,31% | +4,16% | +11,83% | -3,00% | -0,32% | +23,87% | +59,76% | -5,40% | +937,80% | 33,56 Md | |
| -2,09% | -0,80% | +8,59% | -10,02% | +0,42% | +3,56% | +33,56% | -20,85% | +146,58% | 26,84 Md | |
| -0,63% | +2,85% | +33,83% | - | - | - | - | - | - | 17,22 Md | |
| +0,66% | -1,48% | +16,95% | +2,85% | -4,66% | +66,05% | +127,36% | +197,20% | - | 15,19 Md | |
| -23,90% | -18,84% | -12,61% | -14,28% | -18,76% | +55,47% | +53,83% | +65,69% | +153,43% | 13,96 Md | |
| +2,59% | +0,50% | +6,04% | +5,36% | +10,26% | +15,28% | +21,25% | -31,88% | +106,17% | 13,36 Md | |
| +1,99% | -3,59% | +10,86% | +58,41% | -7,38% | +11,34% | -28,62% | -19,38% | +131,99% | 12,68 Md | |
| +0,41% | +4,34% | +37,52% | +21,39% | +1,83% | +1 689,78% | +671,07% | +320,58% | +2 847,12% | 12 Md | |
| +4,30% | +1,97% | +25,30% | +33,43% | +17,10% | +47,48% | +12,91% | -38,40% | +173,15% | 10,79 Md | |
| +0,27% | +0,21% | +35,14% | +28,87% | +20,98% | +35,06% | -11,94% | -38,25% | +147,11% | 11,06 Md | |
| +7,39% | -0,16% | +26,57% | +29,47% | +4,15% | +5,11% | - | - | - | 10,28 Md | |
| +0,24% | +0,60% | +60,91% | +60,70% | +76,96% | +266,85% | - | - | - | 9,99 Md | |
| +4,24% | +4,20% | +60,92% | +36,58% | +52,94% | +174,00% | +429,36% | +139,63% | - | 9,39 Md | |
| -0,94% | +3,98% | +26,69% | +54,67% | +92,21% | +83,05% | +79,99% | +111,40% | +9,87% | 9,05 Md | |
| -1,73% | +9,96% | +40,41% | +34,82% | +57,59% | +176,94% | +494,30% | +203,04% | - | 9,01 Md | |
| +0,04% | +4,23% | +31,54% | +4,03% | +13,02% | +612,40% | +1 750,67% | +12,16% | - | 9,28 Md | |
| Moyenne | +0,76% | +0,94% | +25,37% | +26,47% | +25,41% | +206,82% | +270,32% | +85,55% | +464,22% | 17,37 Md | |
| Moyenne pondérée par Capi. | +0,81% | +0,84% | +21,71% | +26,33% | +26,48% | +166,16% | +208,55% | +93,07% | +431,44% |
Choisissez Zonebourse Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
